The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?
Journal of Child and Adolescent Psychopharmacology · 01.02.2024 · 34 (1) · 1-3
DOI: 10.1089/cap.2023.29254.editorial ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, erschienen am 01.02.2024. Verfasst von Lisa B Namerow und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Connecticut School of Medicine, Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Psychopharmacology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
- Department of Psychiatry & Behavioral Neuroscience, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
- Divisions of Child & Adolescent Psychiatry and Clinical Pharmacology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Zitieren
APA
Namerow, L. B., & Strawn, J. R. (2024). The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?. Journal of Child and Adolescent Psychopharmacology, 34(1), 1-3. https://doi.org/10.1089/cap.2023.29254.editorial
Vancouver
Namerow LB, Strawn JR. The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?. Journal of Child and Adolescent Psychopharmacology. 2024;34(1):1-3. doi:10.1089/cap.2023.29254.editorial
BibTeX
@article{Namerow2024,
author = {Namerow, Lisa B and Strawn, Jeffrey R},
title = {The Pharmacogenetic Journey in Child and Adolescent Psychopharmacology: Are We There Yet?},
journal = {Journal of Child and Adolescent Psychopharmacology},
year = {2024},
volume = {34},
number = {1},
pages = {1--3},
doi = {10.1089/cap.2023.29254.editorial}
}
EUVIMED